Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

Aspirin use can significantly reduce the risk of colorectal cancer

A new report from the Nurse's Health Study finds that regular, long-term aspirin use can significantly reduce the risk of colorectal cancer, as suggested by several earlier studies.

23 Aug 2005

Epidemiological study links heart protection with non-aspirin, non-steroidal drugs

It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.

22 Aug 2005

Separate studies produce conflicting results on race and gender disparities in U.S. health system

Two newly released studies in the U.S. have to some extent come to conflicting results. According to one study, by researchers at Emory University, attempts over the last decade to address race and gender disparities in the treatment of U.S. patients hospitalized for heart attacks, still in some respects raise cause for concern.

18 Aug 2005

Treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race

Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.

17 Aug 2005

Common non-aspirin painkillers linked to high blood pressure in women

Women who consume higher doses of non-aspirin painkillers are much more likely to develop high blood pressure than women who do not use them, according to research reported in Hypertension: Journal of the American Heart Association.

17 Aug 2005

New study shows even non-prescription painkillers raise blood pressure in women

According to a new U.S. study women who take higher doses of common, over-the-counter painkillers, such as Ibuprofen and even Tylenol, have higher blood pressure than women who do not.

16 Aug 2005

Latest findings on aspirin resistance

Treatment failures occur with any drug and aspirin is no exception. Evidence is growing that some people will not respond to the anti-coagulant action of aspirin and the drug will not protect against cardiovascular events despite its regular intake.

9 Aug 2005

Not enough women take part in heart drug trials

Scientists say because women are under-represented in the clinical trials of heart drugs, doctors are left in the dark as to how treatments may work differently in their bodies.

3 Aug 2005

Acetaminophen, when taken as directed, is safe for patients with liver disease

Contrary to common perception, clinical data demonstrate that acetaminophen is an appropriate pain relief choice for patients with chronic liver disease. According to a systematic literature review of the data, which is published in the current issue of the American Journal of Therapeutics, there is no evidence that acetaminophen at therapeutic doses aggravates liver disease.

26 Jul 2005

Does aspirin work equally well for everyone?

We all know that aspirin can help prevent a heart attack or stroke, but does aspirin work equally well for everyone? A growing amount of medical evidence says no. One reason emerging to explain this difference is that some people fail to achieve an adequate response to the drug.

26 Jul 2005

Eplerenone shows benefit for patients with damaged hearts

In the first thirty days following a heart attack, one in three deaths among patients with signs of heart failure may be preventable by early treatment with a drug called eplerenone (Inspra, Pfizer Ltd), according to new data published in the Journal of the American College of Cardiology (JACC).

26 Jul 2005

Evaluating how hospitals deliver medical care standardizes practices and improves care

In recent years, American hospitals have made significant improvements on standardized, evidence-based measures of clinical performance for several medical conditions, including heart attacks, heart failure, and pneumonia.

20 Jul 2005

Vioxx safe enough for Canadian market says health panel

A canadian health advisory panel says that Merck's arthritis drug Vioxx should be allowed to go on sale again in the country, 10 months after the company withdrew the blockbuster painkiller over reports that it increased the risk of heart disease.

11 Jul 2005

Vitamin E fails to deliver benefits for major cardiovascular events or cancer

In an article in the July 6 JAMA, I-Min Lee, M.B.B.S., Sc.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues analyzed data from the vitamin E component of the Women's Health Study, which tested whether vitamin E supplementation decreases the risk of cardiovascular disease and cancer among healthy women.

6 Jul 2005

Aspirin can help prevent heart disease, but vitamin E no protection against cancer

It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.

6 Jul 2005

Vitamin E supplements do not protect healthy women against heart attacks and stroke

Vitamin E supplements do not protect healthy women against heart attacks and stroke, according to new results from the Women's Health Study, a long-term clinical trial of the effect of vitamin E and aspirin on both the prevention of cardiovascular disease and of cancer.

5 Jul 2005

Acetylsalicylic acid, the active ingredient in Aspirin can lower the risk of redeveloping colorectal cancer

Acetylsalicylic acid, the active ingredient in Aspirin®, can lower the risk of redeveloping colorectal cancer: Stage III colon cancer patients, who have undergone surgery and chemotherapy, experience less recurrence and fatalities when using Aspirin®.

4 Jul 2005

New Zealand Ministry of Health warns Influenza B can be serious health risk to children and young people

A currently-circulating strain of influenza has not been common in New Zealand since 1987 and means children and young people can be at particular risk of serious illness, the Ministry of Health says.

21 Jun 2005

First blood test to help predict a patient's risk for ischemic stroke

The U.S. Food and Drug Administration (FDA) has approved the first blood test designed to help predict a patient's risk for ischemic stroke, the most common type of stroke and one of the nation's leading causes of long-term disability affecting approximately 700,000 people per year.

19 Jun 2005

Should everyone over 50 be taking aspirin?

Experts go head to head in this week’s BMJ over whether everyone over 50 should take a daily aspirin to reduce their risk of heart attacks and strokes.

16 Jun 2005

Aspirin News and Research

Aspirin use can significantly reduce the risk of colorectal cancer

Epidemiological study links heart protection with non-aspirin, non-steroidal drugs

Separate studies produce conflicting results on race and gender disparities in U.S. health system

Treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race

Common non-aspirin painkillers linked to high blood pressure in women

New study shows even non-prescription painkillers raise blood pressure in women

Latest findings on aspirin resistance

Not enough women take part in heart drug trials

Acetaminophen, when taken as directed, is safe for patients with liver disease

Does aspirin work equally well for everyone?

Eplerenone shows benefit for patients with damaged hearts

Evaluating how hospitals deliver medical care standardizes practices and improves care

Vioxx safe enough for Canadian market says health panel

Vitamin E fails to deliver benefits for major cardiovascular events or cancer

Aspirin can help prevent heart disease, but vitamin E no protection against cancer

Vitamin E supplements do not protect healthy women against heart attacks and stroke

Acetylsalicylic acid, the active ingredient in Aspirin can lower the risk of redeveloping colorectal cancer

New Zealand Ministry of Health warns Influenza B can be serious health risk to children and young people

First blood test to help predict a patient's risk for ischemic stroke

Should everyone over 50 be taking aspirin?

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News